Welcome to our dedicated page for Bain Capital Specialty Finance SEC filings (Ticker: BCSF), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Bain Capital Specialty Finance, Inc. (NYSE: BCSF) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures as a business development company. BCSF files reports and current reports under the Securities Exchange Act of 1934, including Forms 8-K that describe material events such as earnings releases, dividend declarations, financing transactions and changes in key officers.
In its 8-K filings, BCSF furnishes press releases announcing quarterly and annual financial results, including net investment income, net income per share, net asset value per share, portfolio composition and leverage metrics. These filings also document the declaration of regular quarterly dividends, additional dividends and special dividends, specifying record and payment dates. For example, 8-Ks describe quarterly dividends of $0.42 per share with additional dividends of $0.03 per share for 2025, as well as a special dividend of $0.15 per share.
BCSF’s filings also cover capital structure and financing activities. The company has reported offerings of senior unsecured notes due 2030, including coupon terms and intended use of proceeds, and has disclosed a CLO reset transaction for BCC Middle Market CLO 2019-1, Ltd., a consolidated subsidiary. Related 8-Ks describe the issuance of replacement notes backed by a diversified portfolio of middle-market commercial loans and BCSF’s ongoing role as portfolio manager and retention holder.
Governance and management changes are recorded in 8-K items on the appointment or resignation of certain officers, such as the appointment of a General Counsel or a Vice President. Filings also confirm that BCSF’s common stock, par value $0.001 per share, is registered under Section 12(b) and trades on the New York Stock Exchange under the symbol BCSF.
On Stock Titan, AI-powered tools summarize these SEC filings so readers can quickly understand the key points in lengthy documents. Real-time updates from EDGAR, along with structured access to current reports, annual and quarterly disclosures and other exhibits, help investors analyze Bain Capital Specialty Finance, Inc.’s regulatory reporting history more efficiently.
Bain Capital Specialty Finance, Inc. filed an initial statement of beneficial ownership for Chief Compliance Officer Caroline Willis Hooper on Form 3. This filing establishes her status as a reporting person for the company’s equity securities. The excerpt shows no equity transactions reported in connection with this filing.
Bain Capital Specialty Finance, Inc. General Counsel Sabrina Rusnak-Carlson reported an open-market purchase of common stock. She bought 2,300 shares at a price of $12.55 per share, bringing her directly held stake to a total of 9,560 common shares after this transaction.
Bain Capital Specialty Finance, Inc. reported solid fourth-quarter 2025 results, with net investment income of $29.7M, or $0.46 per share, and earnings per share of $0.43. Regular dividends declared and payable for the quarter were $0.42 per share, supplemented by a special dividend of $0.18 per share.
As of December 31, 2025, the investment portfolio had a fair value of $2,508.4M across 203 companies, with net asset value per share of $17.23. Credit quality indicators remained stable, with non-accruals at 1.5% of amortized cost and 0.8% of fair value. The Board also declared a first-quarter 2026 dividend of $0.42 per share for stockholders of record on March 16, 2026, payable on March 30, 2026.
Bain Capital Specialty Finance (BCSF) details a highly diversified investment portfolio focused on private credit. The holdings are primarily first lien senior secured loans, including revolvers and delayed draw facilities, to borrowers across sectors such as healthcare, technology, financial services, consumer, industrials and transportation.
The schedule also shows exposure to subordinated debt, preferred equity, common equity and warrants, along with numerous forward foreign currency exchange contracts with major banks including Morgan Stanley, Wells Fargo, Bank of New York Mellon, Standard Chartered, BNP Paribas, Goldman Sachs, US Bank and Citibank. Many loans reference SOFR, EURIBOR or SONIA plus contractual spreads, with stated cash and PIK interest components and maturities generally ranging from 2025 through 2033, indicating a long-dated, floating-rate credit book diversified by industry, structure and currency.
Bain Capital Specialty Finance, Inc. is scheduling its next earnings update. The company will report financial results for the fourth quarter and fiscal year ended December 31, 2025 on February 26, 2026 after the market closes, followed by a conference call on February 27, 2026 at 8:00 a.m. Eastern Time.
The company is an externally managed business development company focused on lending to middle-market borrowers. Since beginning investment operations in 2016 and through September 30, 2025, it has invested approximately $9,688.5 million in aggregate principal of debt and equity investments.
Bain Capital Specialty Finance, Inc. entered into a Fourth Supplemental Indenture with U.S. Bank Trust Company to issue $350,000,000 aggregate principal amount of 5.950% notes due 2031.
The Notes mature on March 1, 2031, bear interest at 5.950% per year, and pay interest semi-annually on March 1 and September 1, beginning September 1, 2026. They are general unsecured obligations, ranking senior to expressly subordinated debt, equal with other unsecured unsubordinated debt, effectively junior to secured debt up to the value of collateral, and structurally junior to liabilities of subsidiaries.
The Indenture includes asset coverage and reporting covenants and requires a repurchase offer at 100% of principal plus accrued interest upon a defined change of control repurchase event. The registered offering closed on January 29, 2026 and generated net proceeds of about $342.5 million, which the Company intends to use to repay outstanding secured indebtedness under its financing arrangements and for general corporate purposes.
Bain Capital Specialty Finance, Inc. is issuing $350,000,000 aggregate principal amount of 5.950% senior unsecured notes due March 1, 2031. The notes are priced at 98.935% of face value, pay interest semi-annually on March 1 and September 1 beginning September 1, 2026, and may be redeemed by the company at any time, including at par on or after February 1, 2031, or at a make-whole premium before that date.
The notes rank pari passu with the company’s other unsecured unsubordinated debt, effectively junior to secured borrowings and structurally junior to subsidiary obligations. As of September 30, 2025, total consolidated indebtedness was about $1.5 billion, including approximately $0.5 billion of secured debt and $0.1 billion at subsidiaries. Net proceeds of approximately $342.5 million are expected to be used to repay outstanding secured indebtedness under existing financing arrangements and for general corporate purposes.
Investors receive a change-of-control repurchase right at 100% of principal plus accrued interest if a defined Change of Control Repurchase Event occurs. The notes are not insured by any government agency and are not expected to be listed on any securities exchange, so liquidity will depend on dealer market-making. The company operates as an externally managed business development company focused on senior and mezzanine lending to middle-market borrowers.
Bain Capital Specialty Finance, Inc. entered into an underwriting agreement to issue and sell $350 million aggregate principal amount of its 5.950% Notes due 2031. The agreement is with BCSF Advisors, LP and a group of underwriters led by Wells Fargo Securities, LLC, J.P. Mogan Securities LLC, and SMBC Nikko Securities America, Inc. It contains customary representations, warranties, covenants, indemnification, and contribution provisions for all parties. The notes offering is being conducted under the company’s effective shelf registration statement on Form N-2, using a preliminary and final prospectus supplement each dated January 22, 2026.
Bain Capital Specialty Finance, Inc. plans a public offering of new senior unsecured notes that will pay fixed cash interest semi-annually and mature on a specified future date. The notes may be redeemed early at the company’s option and investors can require repurchase at 100% of principal plus accrued interest if a defined Change of Control Repurchase Event occurs.
The notes will rank equally with the company’s other unsecured unsubordinated debt, be effectively junior to secured borrowings, and structurally junior to obligations of subsidiaries. As of September 30, 2025, total consolidated indebtedness was approximately $1.5 billion, including about $0.5 billion of secured debt and $0.9 billion of direct unsecured indebtedness.
The company expects to use net proceeds primarily to repay outstanding secured indebtedness under its existing financing arrangements and for general corporate purposes, with future borrowings potentially used to fund investments in portfolio companies. The notes are not expected to be listed on an exchange, and an active trading market may not develop.
Bain Capital Specialty Finance, Inc. declared a special cash dividend of $0.15 per share. This one-time dividend will be paid to stockholders who are on the company’s books as of the record date of December 31, 2025, and is scheduled to be paid on January 26, 2026. The company disclosed this action in connection with a press release that provides additional details.